Nicola Tilt

2PUBLICATIONS
19CO-AUTHORS
Social epidemiologyAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 22, 2026
Bimekizumab 2-year efficacy by hidradenitis suppurativa duration: BE HEARD EXT results.

|Jun 05, 2026
Association Between Bimekizumab's Clinical Response and Patient-Reported Benefits on Health-Related Quality of Life: Results from BE HEARD I and II.

Pageof 1

Frequent Collaborators

2 joint publications

Bartosz Lukowski

1 joint publications

Steven Daveluy

1 joint publications

Alice Bendix Gottlieb

1 joint publications

Matthias Augustin